EMA approves new Genzyme plant for Fabrazyme

Genzyme Corp. said EMA approved its Framingham, Mass., manufacturing facility for the production of Fabry's disease therapy Fabrazyme agalsidase beta. Genzyme has experienced supply constraints for Fa...